DK1148881T3 - Anvendelse af pyridazin[4,5-b]indol-1-acetamidderivater til fremstilling af medikamenter beregnet mod sygdomme forbundet med perifere benzodiazepinreceptorers dysfunktion - Google Patents
Anvendelse af pyridazin[4,5-b]indol-1-acetamidderivater til fremstilling af medikamenter beregnet mod sygdomme forbundet med perifere benzodiazepinreceptorers dysfunktionInfo
- Publication number
- DK1148881T3 DK1148881T3 DK00900637T DK00900637T DK1148881T3 DK 1148881 T3 DK1148881 T3 DK 1148881T3 DK 00900637 T DK00900637 T DK 00900637T DK 00900637 T DK00900637 T DK 00900637T DK 1148881 T3 DK1148881 T3 DK 1148881T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyridazine
- indole
- dysfunction
- drugs
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9900806A FR2788696B1 (fr) | 1999-01-26 | 1999-01-26 | Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1148881T3 true DK1148881T3 (da) | 2006-12-11 |
Family
ID=9541212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00900637T DK1148881T3 (da) | 1999-01-26 | 2000-01-21 | Anvendelse af pyridazin[4,5-b]indol-1-acetamidderivater til fremstilling af medikamenter beregnet mod sygdomme forbundet med perifere benzodiazepinreceptorers dysfunktion |
Country Status (32)
Country | Link |
---|---|
US (1) | US6395729B1 (zh) |
EP (1) | EP1148881B1 (zh) |
JP (1) | JP4688295B2 (zh) |
KR (1) | KR100694752B1 (zh) |
CN (1) | CN100577167C (zh) |
AR (1) | AR022413A1 (zh) |
AT (1) | ATE335487T1 (zh) |
AU (1) | AU764445B2 (zh) |
BG (1) | BG65152B1 (zh) |
BR (1) | BR0007718A (zh) |
CA (1) | CA2360754C (zh) |
CO (1) | CO5160242A1 (zh) |
CY (1) | CY1106257T1 (zh) |
CZ (1) | CZ294283B6 (zh) |
DE (1) | DE60029929T2 (zh) |
DK (1) | DK1148881T3 (zh) |
EE (1) | EE04905B1 (zh) |
ES (1) | ES2269097T3 (zh) |
FR (1) | FR2788696B1 (zh) |
HK (1) | HK1040905B (zh) |
HU (1) | HU228670B1 (zh) |
IL (2) | IL144181A0 (zh) |
NO (1) | NO321997B1 (zh) |
NZ (1) | NZ512981A (zh) |
PL (1) | PL193420B1 (zh) |
PT (1) | PT1148881E (zh) |
RU (1) | RU2243764C2 (zh) |
SK (1) | SK285707B6 (zh) |
TR (1) | TR200102134T2 (zh) |
TW (1) | TW541177B (zh) |
UA (1) | UA70349C2 (zh) |
WO (1) | WO2000044384A1 (zh) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2350597A1 (en) * | 1998-12-02 | 2000-06-08 | Barbara Ann Foster | Methods and compositions for restoring conformational stability of a protein of the p53 family |
FR2811897A1 (fr) * | 2000-07-24 | 2002-01-25 | Sanofi Synthelabo | UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1- ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AU TRAITEMENT DES DYSFONCTIONNEMENTS DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES |
FR2838124B1 (fr) * | 2002-04-03 | 2004-05-28 | Sanofi Synthelabo | Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique |
FR2876715B1 (fr) | 2004-10-19 | 2006-12-15 | Profiles Du Ct Sa | Embout de protection pour ecran de glissiere de securite routiere |
GT200600005A (es) * | 2005-01-12 | 2006-08-16 | Un derivado de 2-(aminocarbonilo ciclico)-indolina y una composicion farmaceutica que lo contiene | |
NZ562559A (en) * | 2005-05-05 | 2011-03-31 | Sanofi Aventis Us Llc | Stable nanoparticle formulations smaller than 1000 nm without the use of any surface modifier or stabilizzer absorbed onto the surface of the particles |
ZA200801890B (en) * | 2005-08-29 | 2009-11-25 | Sanofi Aventis Us Llc | Novel crystalline form of a pyridazino (4, 5-B) indole derivative |
CN101272767B (zh) * | 2005-08-29 | 2012-08-29 | 赛诺菲-安万特美国有限责任公司 | 7-氯-N,N,5-三甲基-4-氧-3-苯基-3,5-二氢-4H-哒嗪并[4,5-b]吲哚-1-乙酰胺的无定形固体分散体 |
CN1946120B (zh) * | 2006-10-20 | 2010-05-12 | 华为技术有限公司 | 实现话单关联的方法及系统 |
FR2918563B1 (fr) | 2007-07-12 | 2009-12-04 | Oreal | Composition photoprotectrice fluide aqueuse a base d'un polymere polyamide a terminaison amide tertiaire. |
FR2931064B1 (fr) | 2008-05-14 | 2010-08-13 | Oreal | Composition cosmetique contenant un derive de dibenzoylmethane et un derive de pyrrolidinone; procede de photostabilisation du derive de dibenzoylmethane |
KR20110052640A (ko) * | 2008-08-18 | 2011-05-18 | 사노피-아벤티스 유.에스. 엘엘씨 | 7-클로로-N,N,5-트리메틸-4-옥소-3-페닐-3,5-디하이드로-4H-피리다지노[4,5-b]인돌-1-아세트아미드의 다형체의 제조방법 |
GB0818738D0 (en) * | 2008-10-13 | 2008-11-19 | Ge Healthcare Ltd | Imaging neuroflammation |
FR2936706B1 (fr) | 2008-10-08 | 2010-12-17 | Oreal | Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane |
EP2181717A1 (en) * | 2008-10-28 | 2010-05-05 | Sanofi-Aventis | Use of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-B]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels |
WO2011073576A2 (fr) | 2009-12-18 | 2011-06-23 | L'oreal | Procede de coloration de la peau impliquant un compose apte a condenser in situ et un agent colorant de la peau |
FR2960773B1 (fr) | 2010-06-03 | 2015-12-11 | Oreal | Procedes de traitement cosmetique utilisant un revetement a base d'un polymere polyamide-polyether |
WO2019113248A1 (en) * | 2017-12-07 | 2019-06-13 | The Regents Of The University Of California | Anti-upar antibody-drug conjugates and methods of use thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3121137A1 (de) * | 1981-05-27 | 1982-12-16 | Hoechst Ag, 6000 Frankfurt | Neue pyridazino(4,5-b)indole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen, zwischenprodukte und deren herstellung" |
GB9411955D0 (en) * | 1994-06-15 | 1994-08-03 | Merck Sharp & Dohme | Therapeutic agents |
FR2754262B1 (fr) * | 1996-10-08 | 1998-10-30 | Synthelabo | Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique |
US6031120A (en) * | 1997-07-29 | 2000-02-29 | E. I. Du Pont De Nemours And Company | Selective synthesis of organodiphosphite compounds |
FR2766823B1 (fr) * | 1997-07-30 | 1999-10-08 | Synthelabo | Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique |
FR2788776B1 (fr) * | 1999-01-26 | 2001-02-23 | Synthelabo | Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique |
-
1999
- 1999-01-26 FR FR9900806A patent/FR2788696B1/fr not_active Expired - Fee Related
-
2000
- 2000-01-21 JP JP2000595687A patent/JP4688295B2/ja not_active Expired - Fee Related
- 2000-01-21 IL IL14418100A patent/IL144181A0/xx active IP Right Grant
- 2000-01-21 HU HU0201280A patent/HU228670B1/hu not_active IP Right Cessation
- 2000-01-21 SK SK1050-2001A patent/SK285707B6/sk not_active IP Right Cessation
- 2000-01-21 AT AT00900637T patent/ATE335487T1/de active
- 2000-01-21 CA CA002360754A patent/CA2360754C/en not_active Expired - Fee Related
- 2000-01-21 PL PL00349364A patent/PL193420B1/pl not_active IP Right Cessation
- 2000-01-21 WO PCT/FR2000/000135 patent/WO2000044384A1/fr active IP Right Grant
- 2000-01-21 UA UA2001074907A patent/UA70349C2/uk unknown
- 2000-01-21 EE EEP200100388A patent/EE04905B1/xx not_active IP Right Cessation
- 2000-01-21 CN CN00805273A patent/CN100577167C/zh not_active Expired - Fee Related
- 2000-01-21 TR TR2001/02134T patent/TR200102134T2/xx unknown
- 2000-01-21 DE DE60029929T patent/DE60029929T2/de not_active Expired - Lifetime
- 2000-01-21 ES ES00900637T patent/ES2269097T3/es not_active Expired - Lifetime
- 2000-01-21 CZ CZ20012681A patent/CZ294283B6/cs not_active IP Right Cessation
- 2000-01-21 EP EP00900637A patent/EP1148881B1/fr not_active Expired - Lifetime
- 2000-01-21 DK DK00900637T patent/DK1148881T3/da active
- 2000-01-21 NZ NZ512981A patent/NZ512981A/xx not_active IP Right Cessation
- 2000-01-21 PT PT00900637T patent/PT1148881E/pt unknown
- 2000-01-21 BR BR0007718-6A patent/BR0007718A/pt not_active Application Discontinuation
- 2000-01-21 US US09/889,983 patent/US6395729B1/en not_active Expired - Lifetime
- 2000-01-21 RU RU2001121160/15A patent/RU2243764C2/ru not_active IP Right Cessation
- 2000-01-21 KR KR1020017009272A patent/KR100694752B1/ko not_active IP Right Cessation
- 2000-01-21 AU AU30579/00A patent/AU764445B2/en not_active Ceased
- 2000-01-25 CO CO00003866A patent/CO5160242A1/es unknown
- 2000-01-25 AR ARP000100305A patent/AR022413A1/es not_active Application Discontinuation
- 2000-01-25 TW TW089101179A patent/TW541177B/zh not_active IP Right Cessation
-
2001
- 2001-07-05 IL IL144181A patent/IL144181A/en not_active IP Right Cessation
- 2001-07-24 NO NO20013645A patent/NO321997B1/no not_active IP Right Cessation
- 2001-07-24 BG BG105728A patent/BG65152B1/bg unknown
-
2002
- 2002-01-22 HK HK02100510.9A patent/HK1040905B/zh not_active IP Right Cessation
-
2006
- 2006-11-08 CY CY20061101607T patent/CY1106257T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1148881T3 (da) | Anvendelse af pyridazin[4,5-b]indol-1-acetamidderivater til fremstilling af medikamenter beregnet mod sygdomme forbundet med perifere benzodiazepinreceptorers dysfunktion | |
DE69827419D1 (de) | Pharmazeutische Zusammensetzung, enthaltend 2,3-Diaryl-Pyrazolo[1,5-b]Pyridazin Derivate | |
ID29514A (id) | 2-ARIL-3-(HETEROARIL)-IMIDAZO [1,2-a]PIRIMIDIN TERSUBSTITUSI, DAN METODE-METODE DAN KOMPOSISI-KOMPOSISI FARMASI YANG TERKAIT | |
NO20002977D0 (no) | Terapeutisk formulering for administrasjon av tolterodin med kontrollert frigivelse | |
AU4583899A (en) | Nasal administration of sildenafil for the treatment of erectile dysfunction | |
EP1178786A4 (en) | PHARMACOLOGICALLY ACTIVE PROTEIN STABILIZING AGENTS; METHODS OF MANUFACTURE AND METHODS OF USE | |
NO20005841D0 (no) | Pyrrolo[1,2-b]pyridazinderivater med sPLA2inhiberende effekt | |
PT1674456E (pt) | Utilização de 2-fluoro-3-cetoésteres para preparar 3-fluoro- 6,7,8,9-tetra-hidro-4-h-pirimido[1,2-a]pirimidin-4-onas | |
EE200100377A (et) | Imidaso[1,5-a]-pürido[3,2-e]-pürasinoonide kasutamine arstimitena | |
EP1440689A3 (en) | Treatment of neurotic disorders | |
NZ515882A (en) | Treatment of serotonin related disorders with 2,7-substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives | |
TWI320413B (en) | 1,4-diazabicyclo [ 3.2.2 ] nonanecarboxamide derivatives, preparation thereof and therapeutic use thereof | |
DE60002043D1 (de) | 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b]indol-1-carboxamid-derivate, ihre herstellung und therapeutische verwendung | |
NO20000605D0 (no) | 3-Substituerte 3,4,5,7-tetrahydro-pyrrolo[3',4':4,5]tieno[2,3- D]pyrimidinderivater, deres fremstilling og anvendelse som 5HT- antagonister | |
HUP0204391A3 (en) | The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders | |
DK1071397T3 (da) | Levosimendan-holdige lægemidler til oral indgivelse med kontrolleret frisætning af det aktive middel | |
NO20001894D0 (no) | Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer | |
MXPA03008894A (es) | Uso de compuestos de imidazo[1,2-a]-piridin-3-il-amidas e imidazo [1,2-a]-piridin-3-il-aminas sustituidas como medicamentos. | |
HUP0002736A3 (en) | 3-substituted pyrido [3',4':4,5]thieno[2,3-d]pyrimidine derivatives, and their use for the preparation of pharmaceutical compositions | |
AU2001278549A1 (en) | Use of pyridazino(4,5-)indole-1-acetamide derivatives for preparing medicines for treating pathologies related to the dysfunction of peripheral benzodiazepin receptors | |
PL371201A1 (en) | 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use | |
AU3971800A (en) | 2-alkoxy-cyclobutene-3,4-dione derivatives, preparation and therapeutic use thereof | |
IL203601A (en) | 6-Hello-7-History (optionally converted amino) -Pyrazolo [15, - a] pyrimidine and its use in drug preparation | |
TW382948U (en) | Improved structure for the leg locking structure of chairs | |
EE200100700A (et) | Asendatud [1,4]diasepino[6,7,1-hi]indool-4-oonidevalmistamismeetod |